Simcere Pharmaceutical Co., Ltd: Clinical Trials

3 unknown. 3 Phase 4.

By phase and status

Phase	Trials	Status
Phase 4	3	Unknown 3

Follow Simcere Pharmaceutical Co., Ltd: new trials by email

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Study of Concurrent Chemo-radiotherapy Combined With Recombinant Human Endostatin for Local Advanced Non-small Cell Lung Cancer (NSCLC) radiotherapy combined with EP, radiotherapy / EP combined with recombinant human endostatin - Non-small Cell Lung Cancer	Phase 4	Unknown	Simcere Pharmaceutical Co., Ltd	170	2010-10-01	2010-09-29
A Study of Endostar Combined With Chemotherapy Followed by Endostar Maintenance Therapy to Treat Advanced Non-small Cell Lung Cancer (NSCLC) Endostar, Gemcitabine-Cisplatin chemotherapy - Non-small Cell Lung Cancer (NSCLC)	Phase 4	Unknown	Simcere Pharmaceutical Co., Ltd	120	2009-09-01	2009-12-09
Second-line Therapy Study of Combined Chemotherapy and Endostar to Patients With Non-Small Cell Lung Cancer(NSCLC) Endostar(rh recombinant endostatin) plus Docetaxel, Placebo plus Docetaxel - Advanced NSCLC, Recurrent NSCLC	Phase 4	Unknown	Simcere Pharmaceutical Co., Ltd	300	2008-10-01	2010-01-25

Conditions studied

Carcinoma, Non-Small-Cell Lung (3)

Interventions

Endostatins (2)  ·  Control Groups (1)  ·  Docetaxel (1)  ·  Radiotherapy (1)  ·  endostar protein (1)

Countries

China (3)

Top investigators

Kai LI, professor (1)  ·  Yiping Zhang, Dr. (1)